Catalyst
Slingshot members are tracking this event:
Abeona (ABEO) Enrolls First Patient in Phase 2 Trial Evaluating EB-101 in Epidermolysis Bullosa
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ABEO |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 26, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Enrollment, First Patient, Phase 2 Trial, Eb-101, Epidermolysis Bullosa, Gene Therapy Clinical Trial
